These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [What is safe in the therapy of tachycardic heart arrhythmias?]. Wehr M; Noll B; Krappe J Internist (Berl); 1985 Dec; 26(12):741-9. PubMed ID: 2417980 [No Abstract] [Full Text] [Related]
4. Clinical applications of antiarrhythmic drugs. Lavenne F; de Jonghe D Acta Cardiol Suppl; 1980; (25):27-42. PubMed ID: 6155012 [No Abstract] [Full Text] [Related]
5. [Treatment of supraventricular tachyarrhythmias: drugs or ablation?]. Chimienti M; Barbieri S G Ital Cardiol; 1996 Feb; 26(2):213-26. PubMed ID: 8666179 [No Abstract] [Full Text] [Related]
6. Treatment of life threatening cardiac arrhythmias. Schwartz KM; MacLean WA; Waldo AL Cardiovasc Clin; 1981; 11(3):25-48. PubMed ID: 7011556 [No Abstract] [Full Text] [Related]
7. Beta-adrenergic receptor blocking drugs in the treatment of cardiac arrhythmias. Theilen EO; Wilson WR Med Clin North Am; 1968 Sep; 52(5):1017-29. PubMed ID: 4386418 [No Abstract] [Full Text] [Related]
8. [Unfavorable course of the ventricular preexcitation syndrome. Apropos of 3 cases]. Poveda Sierra J; Pajarón A; Medrano GA Arch Inst Cardiol Mex; 1973; 43(6):837-47. PubMed ID: 4773501 [No Abstract] [Full Text] [Related]
9. Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias. Singh BN N Z Med J; 1973 Dec; 78(504):482-6. PubMed ID: 4130662 [No Abstract] [Full Text] [Related]
12. [Cardiac arrhythmias in the postoperative period of cardiac surgery. Pharmacological treatment]. Gizzi JC Arq Bras Cardiol; 1984 May; 42(5):361-5. PubMed ID: 6210074 [No Abstract] [Full Text] [Related]
13. [Use of ajmaline in the therapy of various heart arrhythmias and comparison with the classic antiarrhythmic drug quinidine]. Scardino R; Colao G; Didonato F; Sepe V Minerva Med; 1970 Sep; 61(78):4289-300. PubMed ID: 4930956 [No Abstract] [Full Text] [Related]
14. [On ajmaline treatment of heart rhythm disorders]. Forster G; Holzmann M Schweiz Med Wochenschr; 1967 Feb; 97(6):185-93 contd. PubMed ID: 4174226 [No Abstract] [Full Text] [Related]
16. [Differential indications for anti-arrhythmia therapy]. Manz M; Wagner WL; Lüderitz B Internist (Berl); 1987 Mar; 28(3):182-9. PubMed ID: 2438248 [No Abstract] [Full Text] [Related]
17. Management of cardiac arrhythmias. Han J Am Fam Physician; 1976 Jan; 13(1):128-38. PubMed ID: 1251787 [No Abstract] [Full Text] [Related]
18. [Risks and rules in the use of anti-arrhythmia agents]. Motté G; Sebag C Arch Mal Coeur Vaiss; 1981 Apr; 74(4):473-9. PubMed ID: 6786244 [No Abstract] [Full Text] [Related]
19. [Di-mono-chloracetyl-ajmaline in the treatment of cardiac rhythm disorders]. Bucour V; Enesco R; Sirbulesco R; Pompilian P Minerva Med; 1970 Jan; 61(5):128-35. PubMed ID: 4189652 [No Abstract] [Full Text] [Related]
20. Arrhythmias and antiarrhythmic agents. Heddle WF; Tonkin AM Med J Aust; 1984 Nov; 141(11):715-8. PubMed ID: 6503764 [No Abstract] [Full Text] [Related] [Next] [New Search]